Premier Diagnostic Health Services Inc.
CNSX : PDH

Premier Diagnostic Health Services Inc.

March 17, 2011 13:08 ET

Premier Diagnostics Announces Market Development Partnership for China

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 17, 2011) - Premier Diagnostic Health Service Inc. ("PDH") (CNSX:PDH) announced today that it has entered into a Letter of Intent with GeneDiagnostic Inc., a clinical research and services company based in Hangzhou, China. The purpose is to enter into a Market Development Partnership Agreement for the marketing of PDH's Full Service Diagnostic Imaging Program in China. This Agreement will detail the specifics and scope of the marketing, sales services, and performance targets to be achieved by GeneDiagnostic.

GeneDiagnostic represents the products and services of several international companies active in various aspects of cancer care in China, including Siemens Diagnostics (US), ZytoVision (Germany) and GeneNews (Canada). GeneDiagnostic has well-established relationships with hospitals, particularly in Shanghai and the provinces of Zhejiang and Jiangsu. Leonhard Braunizer, PDH's Director of International Sales, has been instrumental in forging the relationship with GeneDiagnostic, and is scheduling meetings for finalization of Program details and execution of the Agreement.

"We are pleased that we will be working with GeneDiagnostic as our market development partner in China," said Denis Tusar, CEO of PDH with responsibility for China. "Their experience with hospitals active in the treatment of cancer patients makes them an ideal partner with us for the expansion of our diagnostic imaging services for hospitals in China, adding to our already operating facility at the Military Police Hospital in Beijing. Forging relationships with an experienced team on the ground is part of our comprehensive Marketing Development Program, which is designed to quickly identify and realize on opportunities, and accelerate completion of advantageous joint ventures with hospitals."

"We look forward to working with Premier in the important work of making diagnostic imaging more available to the people of China," said Dr. Mark Han, President of GeneDiagnostic Inc.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

The company is engaged in developing and operating diagnostic imaging clinics in Canada and China, with a focus on PET-CT Scanning ("Positron Emission Tomography – Computed Tomography"). Premier is committed to providing the latest technology to enhance health options and owns and operates the first and only private PET-CT clinic in Western Canada as well as an MRI clinic in collaboration with No. 3 Military Police Hospital in Beijing, China. The Centre for Advanced Diagnostics in Burnaby offers access to the most advanced medical imaging technology available in cancer care today, and is dedicated to meeting today's healthcare needs through delivering exceptional patient care.

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release.

Contact Information